Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
Significantly longer overall and progression-free survival seen among patients with limited-stage small cell lung cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.